Donald Olds
@donaldolds
Director
Building Retension Pharmaceuticals, Inc. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Retension Pharmaceuticals, Inc. was founded in 2023 and has no closure on record.
Named alongside
- John KhabbazDirector
- Jonathan FerrariChairman, Director and Chief Executive Officer
- Jonathan RoiterChief Financial Officer
- Neil CuggyPresident, Director and Chief Operating Officer
- Terry YanofskyDirector
- A. Brian DavisDirector
- Amresh KumarExecutive Officer
- Brian FordInterim Chief Financial Officer
- Carrie D'AndreaExecutive Officer
- Donald N. OldsDirector
- Dr. R. Loch MacdonaldExecutive Officer
- Edward NeugeborenDirector
- Janelle D'AlviseExecutive Officer, Director
At Response Pharmaceuticals, Inc.
- Eric KellerExecutive Officer
- Michael BerendtDirector
- Paul SweetnamExecutive Officer
At Retension Pharmaceuticals, Inc.
- Eric KellerExecutive Officer, Director
- Michael BerendtDirector
Contribution
Donald's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Retension Pharmaceuticals, Inc.Pharmaceutical Preparations; filing with the SEC since 2023Director · Pharmaceuticals · MCLEAN, United States · Founded 2023
- Goodfood Market Corp.Director · Other · SAINT-LAURENT
- Grace Therapeutics, Inc.Pharmaceutical Preparations; formerly Acasti Pharma Inc.; listed on Nasdaq as GRCE; filing with the SEC since 2008Director · Biotechnology · Princeton, United States
- Response Pharmaceuticals, Inc.Director · Pharmaceuticals · MCLEAN, United States · Founded 2021